---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-045637"
form_type: "8-K"
ticker: null
cik: "0001697532"
company_name: "Applied Therapeutics, Inc."
filed_at: "2023-04-14T23:59:59+00:00"
generated_at: "2026-06-17T02:00:43.725208+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Applied Therapeutics receives Nasdaq notice for low bid price; 180 days to regain compliance

## Summary
- Nasdaq notified APLT on April 11, 2023, of non-compliance with minimum $1.00 bid price rule for 30 consecutive business days.
- Company has until October 9, 2023, to close at $1.00 or more for at least 10 consecutive business days.
- If not compliant by October 9, APLT may transfer to Nasdaq Capital Market for an additional 180-day grace period.
- No specific remedial plan announced; compliance not guaranteed.

## SEC filing metadata
- accession: 0001104659-23-045637
- form_type: 8-K
- cik: 0001697532
- company_name: Applied Therapeutics, Inc.
- filed_at: 2023-04-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1697532/000110465923045637/0001104659-23-045637-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1697532/000110465923045637/tm2312880d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-045637
- JSON: https://secwatch.observer/filing/0001104659-23-045637.json
- Plain text: https://secwatch.observer/filing/0001104659-23-045637.txt

## Key facts
- Listing & Compliance Notices
  Applied Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: April 11, 2023, Applied Therapeutics, Inc. (the “Company”) received written notification (the “Notice”) from the Nasdaq Stock Market (“Nasdaq”) that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market, pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Market. Pursuant to Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697532/000110465923045637/0001104659-23-045637-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.